24-Hour Oxygen Therapy fails to Add Survival Benefit Over 15-Hour oxygen Therapy for Severe Hypoxemia: NEJM Jacinthlyn Sylvia14 Sept 2024 2:15 AM ISTA recent study published in the New England Journal of Medicine journal found that extending long-term oxygen therapy (LTOT) to 24 hours a day...
Medical Bulletin 12/ September/ 2024 Dr. Garima Soni12 Sept 2024 3:00 PM ISTHere are Top Medical News of the Day:Gene Therapy Improves Vision in hereditary blindness: Study FindsBothnia dystrophy is a form of hereditary...
Randomised Trial Finds Obesity Medication Liraglutide Safe and Effective For Children Under 12 Dr. Garima Soni12 Sept 2024 8:30 AM ISTThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research presented at the annual meeting of the...
Plozasiran Reduces Triglycerides and Pancreatitis Risk in Persistent Chylomicronemia Patients: NEJM Jacinthlyn Sylvia11 Sept 2024 8:00 AM ISTA new study published in the New England Journal of Medicine highlighted the effectiveness of plozasiran, a small interfering RNA, in managing...
Clinical Trial finds Adding Certain Anticoagulant Drugs ineffective for Stroke Patients Dr. Garima Soni6 Sept 2024 8:00 AM ISTStroke patients who survive a blood clot in the brain's blood vessels are prone to developing new blockages during their recovery periods, even if...
Phase 2 Data results promising: Monoclonal Antibody Lu AG09222 Reduces Migraine Days Significantly Over Placebo Medha Baranwal6 Sept 2024 5:30 AM ISTDenmark: A recent Phase 2 clinical trial (HOPE trial) has yielded promising results for a new treatment aimed at preventing migraines. The trial...
Finerenone may reduce worsening heart failure and cardiovascular death, finds study, ESC 2024 Dr. Kamal Kant Kohli4 Sept 2024 6:00 AM ISTFinerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and...
Single blood test may predict 30-year cardiovascular disease risk for women: NEJM Dr. Kamal Kant Kohli2 Sept 2024 9:00 AM ISTResearch supported by the National Institutes of Health has found that measuring two types of fat in the bloodstream along with C-reactive protein...
Nipocalimab Delays or Prevents Fetal Anemia and Intrauterine Transfusions in High-Risk HDFN Pregnancies: NEJM Medha Baranwal29 Aug 2024 8:00 PM ISTUSA: A recent phase 2 study has revealed that nipocalimab, an investigational treatment, demonstrates significant benefits in managing early-onset...
Crinecerfont therapy tied to reduced adrenal androgen production and lower glucocorticoid administration in CAH patients: NEJM Medha Baranwal29 Aug 2024 9:00 AM ISTUSA: A Phase 3 clinical trial has demonstrated that crinecerfont, a novel therapeutic agent, significantly reduces glucocorticoid doses in adults with...
Strategy of mass distribution of Azithromycin shows Potential in Reducing Childhood Mortality: NEJM Jacinthlyn Sylvia29 Aug 2024 7:45 AM ISTA recent study highlighted a promising intervention to combat childhood mortality in sub-Saharan Africa through the mass distribution of azithromycin....
Pivotal study supports belzutifan approval for patients with advanced kidney cancer Dr Kartikeya Kohli25 Aug 2024 8:00 PM ISTBelzutifan is a hypoxia-inducible factor 2 Alpha inhibitor that has showed clinical activity in clear-cell renal-cell carcinoma in early-phase...
